Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis Therapy
Findings from Boston University broaden understanding of arthritis therapy
September 13th, 2008
A new study, 'Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: the jury is still out,' is now available. "To examine the role of anti-tumor necrosis factor (anti-TNF) agents in predicting work disability in subjects with rheumatoid arthritis (RA). We studied 953 subjects with rheumatologist-diagnosed RA from a US cohort using a nested, matched, case-control approach," scientists in the United States report. "Subjects provided data on medication usage and employment every 6 months for 18 months, were employed at baseline, and were age <65 years at last followup. Cases were subjects who were not employed at...
Source: Law & Health Weekly (2008-09-13)
|
